HIV & AIDS

New therapeutic target for HIV identified

Scientists in Montreal and London have identified the key role played by transcription factor RORC2 in HIV infection: the molecule attaches itself to parts of the virus's genome yet doesn't prevent it from replicating.

HIV & AIDS

Oral health in HIV+ population

Pushpa Pandiyan, associate professor of biological sciences in the School of Dental Medicine, and a team of researchers have been working to discover the cause behind residual systemic inflammation and dysfunction of the ...

Medications

Awareness of, referral to HIV PrEP low among Hispanics

(HealthDay)—About one in four Hispanic persons tested for HIV are aware of preexposure prophylaxis (PrEP) and about one in five of those eligible for referral are referred to PrEP providers, according to research published ...

HIV & AIDS

HIV linked with increased risk of sudden cardiac death

People living with human immunodeficiency virus (HIV) have a higher risk of sudden cardiac death than people who do not have HIV, especially if the virus is not well-controlled or if they have other heart disease risk factors, ...

Medications

Cabotegravir bests TDF-FTC for HIV prevention in those at risk

(HealthDay)—For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine ...

HIV & AIDS

Is it possible to deliver a knockout punch to HIV?

With a global focus on strategies to curb expansion of a fast-moving coronavirus pandemic, the question again has arisen: What more is being done about HIV, a scourge that has lasted more than 40 years—is a cure finally ...

page 11 from 40